The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?

Critical Reviews in Oncology/Hematology

Volumn 42, Issue 1, 2002, Pages 65-78

  Kwok, Juliana C ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Iron metabolism; Melanotransferrin; Transferrin; Transferrin receptor 1; Transferrin receptor 2

Indexed keywords

CERULOPLASMIN; FERRITIN; FREE RADICAL; HEMOSIDERIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

CELL CYCLE; CHO CELL; DNA SYNTHESIS; FERRITIN BLOOD LEVEL; HUMAN; IRON KINETICS; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; MACROPHAGE; NONHUMAN; REVIEW; TUMOR CELL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIVISION; CERULOPLASMIN; ENDOCYTOSIS; ESTROGENS; FERRITINS; HUMANS; IRON; NEOPLASM PROTEINS; NEOPLASMS; NONHEME IRON PROTEINS; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 0036118607     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00213-X     Document Type: Review

References (156)

1. The potential of analogues of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents III: the effect of the ligands on molecular targets involved in proliferation
2. Effect of iron chelators with potent anti-proliferative activity on the expression of molecules involved in cell cycle progression and proliferation
3. Modulation of cell surface iron transferrin receptors by cellular density and the state of activation
4. Transferrin biochemistry, physiology and clinical significance
5. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation
6. The uptake of iron and transferrin by the human melanoma cell
7. Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate
8. Transferrin receptor-independent uptake of diferric transferrin by human hepatoma cells with antisense inhibition of receptor expression
9. Inhibition of gallium-67 uptake in melanoma by an anti-human transferrin receptor monoclonal antibody
10. Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin receptor-independent mechanisms
11. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits tumor cell growth in vitro
12. Iron withholding a defense against infection and neoplasia
13. Inactivation of ribonucleotide reductase by nitric oxide
14. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involved the FeS prosthetic group and is reversible
15. Differentiation of murine macrophages to express non-specific cytotoxicity for tumor target cells results in L-arginine-dependent inhibition of mitochondrial iron-sulphur enzymes in the macrophage effector cells
16. Iron depletion. Possible cause of tumor cell cytotoxicity induced by activated macrophages
17. Nitric oxide: a cytotoxic activated macrophage effector molecule
18. Activation of macrophage cytotoxic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide mediated cytostasis
19. Nitrogen monoxide (NO) activates IRP-RNA binding by two possible mechanisms-an effect on the Fe-S cluster and iron release from cells
20. Nitrogen monoxide decreases iron uptake from transferrin but does not mobilise iron from prelabelled neoplastic cells
21. Examination of the mechanism of action of nitrogen monoxide on iron uptake from transferrin
22. Effects of nitrogen monoxide on cellular iron metabolism
23. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
24. Function and regulation of transferrin and ferritin
25. Transferrin receptors and iron uptake during erthroid cell development
26. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
27. The haemochromatosis founder mutation in HLA-H disrupts beta(2) microglobulin interaction and cell surface expression
28. Crystal structure of the haemochromatosis protein HFE and characterisation of its interaction with transferrin receptor
29. The haemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
30. Transferrin receptor is negatively modulated by the haemochromatosis protein HFE: implications for cellular iron homeostasis
31. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis
32. Transferrin and iron uptake by rat hepatocytes in culture
33. The mechanisms of iron uptake by rat fetal hepatocytes
34. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake
35. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family
36. Transferrin receptor 2-α supports cell growth both in iron-chelated cultured cells and in vivo
37. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis
38. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle
39. Membrane transport of non-transferrin-bound iron by reticulocytes
40. Cloning and characterization of a mammalian proton-coupled metal-ion transporter
41. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
42. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport
43. The role of ceruloplasmin in iron metabolism
44. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I
45. Mobilization of liver iron by ferroxidase (ceruloplasmin)
46. Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells
47. The role of ceruloplasmin and ascorbate in cellular iron release
48. The release of iron and transferrin by the human melanoma cell
49. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism
50. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans
51. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
52. Another jigsaw piece towards solving the iron metabolism puzzle: the cloning of the iron exporter, ferroportin 1
53. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone
54. Low molecular weight intracellular iron transport compounds
55. Transferrin and iron distribution in subcellular fractions of K562 cells in early stages of transferrin endocytosis
56. Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism
57. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells
58. Copper chaperones: function, structure and copper-binding properties
59. Ferritin: structure, biosynthesis and role in iron metabolism
60. The ferritins: molecular properties, iron storage function and cellular regulation
61. Ferritin in serum. Clinical and biochemical implications
62. Serum ferritin: does it differ from tissue ferritin
63. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron
64. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
65. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake
66. Interferon-γ and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low molecular mass complexes by macrophages
67. Iron regulates intracellular degradation of iron regulatory protein 2 by the proteasome
68. Iron transport and storage proteins
69. Methods for growth of cultured cells in serum-free medium
70. Transferrin synthesis by inducer T lymphocytes
71. Sertoli cells synthesize and secrete transferrin-like protein
72. Secretion of transferrin by human breast cancer cells
73. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation
74. Transferrin-like autocrine growth factor, derived from T-lymphoma cells, that inhibits normal T-cell proliferation
75. Purification and characterization of an estrogen-inducible membrane glycoprotein. Evidence that it is a transferrin receptor
76. The chicken oviduct and embryonic red blood cell transferrin receptors are distinct molecules
77. The estrogen-inducible transferrin receptor-like membrane glycoprotein is related to stress-regulated proteins
78. An estrogen inducible 104 kDa chaperone glycoprotein binds ferric iron containing proteins: a possible role in intracellular iron trafficking
79. Body iron stores and the risk of cancer
80. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
81. Cell kinetics (SAMBA200) of estradiol stimulated long-term phenol red withdrawn cultured breast cancer cells
82. Serum transferrin receptor level is not altered in invasive adenocarcinoma of the breast
83. Non-transferrin donors of iron for heme synthesis in immature erythroid cells
84. Characterization of a transferrin-independent uptake system for iron in HeLa cells
85. The uptake of inorganic iron complexes by human melanoma cells
86. Regulation of the transferrin-independent iron transport system in cultured cells
87. Identification of a mechanism of iron uptake by cells that is stimulated by hydroxyl radicals generated via the iron-catalyzed Haber-Weiss reaction
88. Despite structural similarities between gp91phox and FRE1, flavocytochrome b558 does not mediate iron uptake by myeloid cells
89. Functional expression cloning and characterization of SFT, a stimulator of Fe transport
90. Structural and functional analysis of SFT, a stimulator of Fe transport
91. Expression of SFT (stimulator of Fe transport) is enhanced by iron chelation in HeLa cells and by hemochromatosis in liver
92. Identification of a cell surface protein, p97, in human melanoma and certain other neoplasms
93. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues
94. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies
95. Human melanoma antigen p97 is structurally and functionally related to transferrin
96. Primary structure of human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence
97. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance
98. Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells
99. In situ localization of melanotransferrin (melanoma-associated antigen P97) in human liver. A light- and electron- microscopic immunohistochemical study
100. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin
101. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium
102. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease
103. Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease
104. A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncaveolar microdomains at the apical surface of fetal intestinal epithelial cells
105. The eosinophil-specific cell surface antigen, EOS47, is a chicken homologue of the oncofetal antigen melanotransferrin
106. Expression of membrane-bound transferrin-like protein p97 on the cell surface of chondrocytes
107. Assignment of the gene for human melanoma-associated antigen p97 to chromosome 3
108. Transferrins: insights into structure and function from studies on lactoferrin
109. Human melanotranferrin (p97) has only one functional iron-binding site
110. Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein
111. A novel iron uptake mechanism mediated by GPI-anchored human p97
112. The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells
113. The role of melanotransferrin (tumor antigen p97) in iron uptake by the human malignant melanoma cell
114. Role of melanotransferrin (p97) in non-transferrin iron uptake by HeLa and K562 cells
115. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2
116. The reduction of ribonucleotides
117. Continual presence of oxygen and iron is required for mammalian ribonucleotide reduction: possible regulation mechanism
118. HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two colour flow cytometric analysis
119. The p97 antigen is mapped to the q24-qter region of chromosome 3; the same region as the transferrin receptor
120. A molecular model for the tumour-associated antigen, p97, suggests a Zn-binding function
121. The membrane-bound transferrin homologue melanotransferrin: roles other than iron transport?
122. Iron metabolism in eukaryotes: Mars and Venus at it again
123. Effect of ceruloplasmin on plasma iron in copper-deficient swine
124. The possible significance of ferrous oxidase activity of ceruloplasmin in normal human serum
125. Role of ceruloplasmin in cellular iron uptake
126. The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake
127. Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism
128. Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer
129. Serum and tumour ferritins in primary liver cancer
130. Serum ferritin as a guide to therapy in neuroblastoma
131. Neuroblastomas contain iron-rich ferritin
132. Iron and neoplasia: ferritin and hemosiderin in tumor cells
133. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children
134. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: the Children's Cancer Study Group experience
135. Human ferritins present in the sera of nude mice transplanted with human neuroblastoma or hepatocellular carcinoma
136. Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function
137. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages
138. Basic and acid isoferritins in the sera of patients with neuroblastoma
139. Stimulation of growth of neuroblastoma cells by ferritin in vitro
140. Purification of a cell growth factor from a human lung cancer cell line: its relationship with ferritin
141. Purification and characterization of a cell growth factor from a human leukemia cell line: immunological identity with ferritin
142. Interaction of acidic isoferritins with human promyelocytic HL60 cells
143. Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines
144. Identification of H- and L-ferritin subunit binding sites on human T and B lymphoid cells
145. Specific binding of placental acidic isoferritins to cells of the T-cell line HD-MAR
146. Distribution of ferritin receptors and coated pits on giant HeLa cells
147. Preferential repression of the H-subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts
148. Coordinated regulation of iron-controlling genes H-ferritin and IRP2, by c-MYC
149. Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell line
150. Ampification of N-myc in untreated neuroblastomas correlates with advanced disease stage
151. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor
152. Chromosomal localization in normal human cells and neuroblastomas of a gene related to c-myc
153. Ferritin production and desferrioxamine cytotoxicity in human neuroblastoma cell lines